BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25057794)

  • 21. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
    Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
    Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of transgenic fibroblasts expressing pancreas‑specific and doxycycline-inducible ICER Iγ for the establishment of a porcine model of human diabetes mellitus.
    Kang HY; Jung EM; Hong EJ; Hyun SH; Hwang WS; Jeung EB
    Mol Med Rep; 2014 Aug; 10(2):1136-42. PubMed ID: 24859238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranolazine increases β-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice.
    Ning Y; Zhen W; Fu Z; Jiang J; Liu D; Belardinelli L; Dhalla AK
    J Pharmacol Exp Ther; 2011 Apr; 337(1):50-8. PubMed ID: 21228065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destruction of pancreatic beta-cells by transgenic induction of prostaglandin E2 in the islets.
    Oshima H; Taketo MM; Oshima M
    J Biol Chem; 2006 Sep; 281(39):29330-6. PubMed ID: 16873378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells.
    Kato I; Oya T; Suzuki H; Takasawa K; Ichsan AM; Nakada S; Ishii Y; Shimada Y; Sasahara M; Tobe K; Takasawa S; Okamoto H; Hiraga K
    Diabetes Metab Res Rev; 2008 Sep; 24(6):486-97. PubMed ID: 18551708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
    Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14.
    Klinger S; Poussin C; Debril MB; Dolci W; Halban PA; Thorens B
    Diabetes; 2008 Mar; 57(3):584-93. PubMed ID: 18025410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved outcome of islet transplantation in partially pancreatectomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin.
    Kim YS; Oh SH; Park KS; No H; Oh BJ; Kim SK; Jung HS; Kim JH; Lee MS; Lee MK; Kim KW
    Pancreas; 2011 Aug; 40(6):855-60. PubMed ID: 21747318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells.
    Inada A; Hamamoto Y; Tsuura Y; Miyazaki J; Toyokuni S; Ihara Y; Nagai K; Yamada Y; Bonner-Weir S; Seino Y
    Mol Cell Biol; 2004 Apr; 24(7):2831-41. PubMed ID: 15024072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of androgen insensitivity on diabetogenesis in db/db male mice with testicular feminization (Tfm).
    Prochazka M; Leiter EH
    Horm Metab Res; 1991 Apr; 23(4):149-54. PubMed ID: 1874472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
    Soto C; Raya L; Juárez J; Pérez J; González I
    Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice.
    Jung HS; Ahn YR; Oh SH; Kim YS; No H; Lee MK; Kim KW
    Transplantation; 2009 Aug; 88(3):354-9. PubMed ID: 19667937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice.
    Yao XG; Xu X; Wang GH; Lei M; Quan LL; Cheng YH; Wan P; Zhou JP; Chen J; Hu LH; Shen X
    J Endocrinol; 2015 Mar; 224(3):327-41. PubMed ID: 25572265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
    He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
    Novelli M; Canistro D; Martano M; Funel N; Sapone A; Melega S; Masini M; De Tata V; Pippa A; Vecoli C; Campani D; De Siena R; Soleti A; Paolini M; Masiello P
    Eur J Pharmacol; 2014 Apr; 729():37-44. PubMed ID: 24530416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.